WOCKPHARMA - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 19 Sept 25, 2:16 pm

Technical Rating: 3.6

Here’s a detailed technical analysis of Wockhardt Ltd (WOCKPHARMA)

📊 Trend Overview

Current Trend: The stock is in a sideways consolidation phase, hovering near its 50-DMA and showing signs of indecision.

Price Action: Trading at ₹1,526, just below the 50-DMA (₹1,537) and above the 200-DMA (₹1,419), suggesting a neutral bias with potential for reversal or breakout.

📈 Momentum Indicators

RSI (51.4): Neutral zone. Indicates balanced momentum with no strong directional bias.

MACD (-2.04): Negative crossover, signaling weakening momentum and potential short-term bearish pressure.

Volume: Current volume (2.05 lakh) is below the 1-week average (2.47 lakh), showing reduced participation and lack of conviction.

📉 Moving Averages

Indicator Value (₹) Signal

50-DMA 1,537 Resistance

200-DMA 1,419 Support

Current Price 1,526 Consolidating between DMAs

📌 Bollinger Bands

Price is near the middle band, suggesting consolidation.

A breakout above ₹1,540–₹1,550 could trigger a move toward ₹1,600+.

🧭 Support & Resistance Zones

Immediate Support: ₹1,500–₹1,510 zone

Major Support: ₹1,420–₹1,450 zone

Immediate Resistance: ₹1,540–₹1,560 zone

Major Resistance: ₹1,650–₹1,700, then ₹1,870 (52-week high)

🎯 Entry & Exit Zones

Optimal Entry: ₹1,500–₹1,510 (on pullback with MACD flattening)

Exit Zone: ₹1,650–₹1,700 (first resistance), ₹1,850+ if momentum builds

🔍 Conclusion

WOCKPHARMA is currently consolidating, with weak momentum signals. RSI is neutral, MACD is negative, and volume is light. Price action between the 50-DMA and 200-DMA suggests indecision. A breakout above ₹1,550 with volume could confirm trend continuation, while a pullback to ₹1,500 offers a favorable entry. The stock remains in a neutral-to-bearish phase unless momentum improves.

Let me know if you’d like a comparison with other pharma stocks like Lupin or Aurobindo Pharma!

Edit in a page